Indaptus Therapeutics, Inc. Income Taxes Paid
Indaptus Therapeutics, Inc. (INDP) reported Income Taxes Paid of $2.40 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2022-08-08
- Indaptus Therapeutics, Inc. income taxes paid for the quarter ending 2021-12-31 was $0.00.
- Indaptus Therapeutics, Inc. income taxes paid for the quarter ending 2021-09-30 was $0.00.
- Indaptus Therapeutics, Inc. income taxes paid for the quarter ending 2021-06-30 was $0.00.
- Indaptus Therapeutics, Inc. income taxes paid for the quarter ending 2021-03-31 was $800.00.
- Indaptus Therapeutics, Inc. income taxes paid for fiscal 2021 was $800.00, a 0.00% change from fiscal 2020.
- Indaptus Therapeutics, Inc. income taxes paid for fiscal 2020 was $800.00.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2022-06-30 | $2.40K 10-Q · filed 2022-08-08 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $0.00 derived: sum of 2 quarters · filed 2022-03-21 | $0.00 derived: sum of 3 quarters · filed 2022-08-08 | $800.00 10-K · filed 2022-03-21 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2022-08-08 | $800.00 10-Q · filed 2021-11-15 | $800.00 derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $800.00 10-Q · filed 2022-08-08 | $800.00 derived: sum of 3 quarters · filed 2022-08-08 | |
| 2021-03-31 | $800.00 10-Q · filed 2022-05-12 | $800.00 derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $800.00 10-K · filed 2022-03-21 | ||
| 2020-09-30 | $800.00 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |